Lirafit Injection is a GLP-1 receptor agonist (liraglutide-based) injectable formulation used under strict medical supervision for approved therapeutic indications. Ernest Impex is a trusted pharmaceutical exporter from India, supplying Lirafit Injection to licensed hospitals, clinics, and distributors worldwide with full regulatory and export compliance.
We export Lirafit Injection to major international healthcare markets, including:
Washington, USA
London, UK
Riyadh, Saudi Arabia
Bangkok, Thailand
Canberra, Australia
Singapore
Kingston
All shipments are handled with secure cold-chain management (where applicable) and delivered via DHL / FedEx / Aramex.
💉 What is Lirafit Injection?
Lirafit Injection contains liraglutide, a long-acting GLP-1 analogue administered subcutaneously as prescribed by a healthcare professional. It is supplied as a ready-to-use injection/pen system suitable for controlled clinical use.
Key highlights
Dosage form: Injectable (subcutaneous)
Category: GLP-1 receptor agonist
Use: Prescription-only; medical supervision required
Quality: Pharmaceutical / export grade
Product composition, strength, and pack details are shared only with licensed buyers, in accordance with country-specific regulations.
🚚 Why Global Buyers Choose Ernest Impex
✔ GMP & ISO-aligned sourcing
✔ Export documentation: COA, MSDS, COO, Invoice, Packing List
✔ Bulk supply & dropshipping support for authorized partners
✔ Cold-chain & temperature-controlled logistics
✔ Reliable international delivery & after-sales coordination
Explore our global pharmaceutical export portfolio:
👉 https://www.ernestimpex.com
👉 https://www.ernestpharmaceuticals.com
Follow us for verified product updates:
@ErnestImpex | @ErnestPharmaceutical
📦 Export Markets Served
USA • UK • Saudi Arabia • Thailand • Australia • Singapore • Jamaica
Door-to-door logistics with compliance, tracking & support.
📩 Contact Ernest Impex
📧 exports@ernestpharmaceuticals.com
🌐 Global Pharmaceutical Exporter from India
📲 WhatsApp: +91 93599 02383
